Thr411

Site Information
ETAGGVMtVLIkRNt SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 17435850

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	gastric cancer ( 2 ) , gastric carcinoma ( 2 ) , lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	MKN-45 (gastric) ( 2 ) , NCI-H3255 (pulmonary) ( 1 )

References
1	Moritz A (2010) CST Curation Set: 10242; Year: 2010; Biosample/Treatment: cell line, NCI-H3255/DMSO; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Curated Info
2	Possemato A (2010) CST Curation Set: 9177; Year: 2010; Biosample/Treatment: cell line, MKN-45/untreated; Disease: gastric carcinoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY] Curated Info